Solasia Pharma KK operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Solasia Pharma KK with three other
pharmaceutical manufacturers in Asia:
Innovent Biologics Inc
of Hong Kong
sales of 11.22 million Hong Kong Dollars [US$1.43 million]
of which 100%
Helixmith Co Ltd
of South Korea
(5.28 billion Korean Won [US$4.44 million]
of which 60%
was Drug Medicine Research and Development), and
based in South Korea
(3.86 billion Korean Won [US$3.24 million]
of which 48%
was Finished Goods).